Karyopharm Therapeutics Inc (KPTI)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -55.366 | -71.523 | -68.423 | -62.749 | -64.562 | -40.135 | -49.826 | -47.81 |
Return on Equity (%) | -60.773 | -88.434 | -114.132 | -171.363 | -391.294 | 852.048 | 343.18 | 187.226 |
Return on Invested Capital (%) | -79.099 | -120.866 | -93.973 | -86.049 | -114.606 | -92.518 | -128.272 | -139.717 |
Operating Margin (%) | -71063.636 | -8032.461 | -579.8 | -449.718 | -156.196 | -46.599 | -89.083 | -81.456 |
Net Profit Margin (%) | -71153.896 | -8036.386 | -588.103 | -488.079 | -181.591 | -59.14 | -105.231 | -97.991 |
Book Value Per Share | 3.873 | 2.614 | 3.011 | 0.761 | 0.684 | -1.052 | -0.147 | -1.189 |
Earnings Per Share | -2.616 | -2.604 | -2.933 | -3.053 | -2.655 | -1.638 | -1.46 | -1.249 |
Cash Per Share | 1.186 | 1.393 | 1.94 | 1.971 | 1.162 | 2.514 | 1.194 | 0.456 |
Working Capital Per Share | 2.749 | 1.998 | 4.73 | 3.552 | 2.926 | 2.665 | 2.511 | 1.436 |
Operating Profit Per Share | 0.004 | 0.032 | 0.499 | 0.589 | 1.426 | 2.725 | 1.341 | 1.232 |
EBIT Per Share | -2.613 | -2.603 | -2.932 | -3.053 | -2.651 | -1.635 | -1.457 | -1.247 |
EBITDA Per Share | -2.613 | -2.603 | -2.932 | -3.053 | -2.651 | -1.635 | -1.457 | -1.247 |
Free Cash Flow Per Share | -2.631 | -2.617 | -2.906 | -3.065 | -2.666 | -1.646 | -1.464 | -1.254 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 41,89M | 49,53M | 60,83M | 65,37M | 73,92M | 75,75M | 113,21M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 113,21M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -73.167 | N/A | N/A | N/A | -94.811 | N/A | N/A |
Net Profit Margin (%) | N/A | -88.185 | N/A | N/A | N/A | -112.788 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 83,53M |
Ratio cours/bénéfice | -0,59 |
Ratio prix/ventes | 0,57 |
Ratio prix/liquidités | 1,61 |
Ratio prix/valeur comptable | -0,62 |
Rendement de dividende | - |
Actions en circulation | 125,31M |
Volume moyen (1 semaine) | 1,38M |
Volume moyen (1 mois) | 920,6k |
Variation sur 52 semaines | -15,62% |
Plus haut sur 52 semaines | 1,95 |
Plus bas sur 52 semaines | 0,65 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales